Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.

Radif Y, Ndiaye H, Kalantzi V, Jacobs R, Hall A, Minogue S, Waugh MG.

Mol Cell Biochem. 2018 Nov;448(1-2):275-286. doi: 10.1007/s11010-018-3332-x. Epub 2018 Feb 15.

2.

The Many Roles of Type II Phosphatidylinositol 4-Kinases in Membrane Trafficking: New Tricks for Old Dogs.

Minogue S.

Bioessays. 2018 Feb;40(2). doi: 10.1002/bies.201700145. Epub 2017 Dec 27. Review.

PMID:
29280156
3.

Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein.

Rowczenio D, Stensland M, de Souza GA, Strøm EH, Gilbertson JA, Taylor G, Rendell N, Minogue S, Efebera YA, Lachmann HJ, Wechalekar AD, Hawkins PN, Heimdal KR, Selvig K, Lægreid IK, Demoulin N, Aydin S, Gillmore JD, Wien TN.

Kidney Int Rep. 2016 Nov 19;2(3):461-469. doi: 10.1016/j.ekir.2016.11.005. eCollection 2017 May.

4.

Phosphatidylinositol 4-kinase IIβ negatively regulates invadopodia formation and suppresses an invasive cellular phenotype.

Alli-Balogun GO, Gewinner CA, Jacobs R, Kriston-Vizi J, Waugh MG, Minogue S.

Mol Biol Cell. 2016 Dec 15;27(25):4033-4042. Epub 2016 Oct 26.

5.

PtdIns4KIIα generates endosomal PtdIns(4)P and is required for receptor sorting at early endosomes.

Henmi Y, Morikawa Y, Oe N, Ikeda N, Fujita A, Takei K, Minogue S, Tanabe K.

Mol Biol Cell. 2016 Mar 15;27(6):990-1001. doi: 10.1091/mbc.E15-08-0564. Epub 2016 Jan 28.

6.

DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.

Borghesan M, Fusilli C, Rappa F, Panebianco C, Rizzo G, Oben JA, Mazzoccoli G, Faulkes C, Pata I, Agodi A, Rezaee F, Minogue S, Warren A, Peterson A, Sedivy JM, Douet J, Buschbeck M, Cappello F, Mazza T, Pazienza V, Vinciguerra M.

Cancer Res. 2016 Feb 1;76(3):594-606. doi: 10.1158/0008-5472.CAN-15-1336. Epub 2016 Jan 15.

7.

Modeling the effects of cyclodextrin on intracellular membrane vesicles from Cos-7 cells prepared by sonication and carbonate treatment.

Kilbride P, Woodward HJ, Tan KB, Thanh NT, Chu KM, Minogue S, Waugh MG.

PeerJ. 2015 Oct 27;3:e1351. doi: 10.7717/peerj.1351. eCollection 2015.

8.

Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma.

Mohamed FE, Al-Jehani RM, Minogue SS, Andreola F, Winstanley A, Olde Damink SW, Habtesion A, Malagó M, Davies N, Luong TV, Dhillon AP, Mookerjee RP, Dhar DK, Jalan R.

Liver Int. 2015 Mar;35(3):1063-76. doi: 10.1111/liv.12626. Epub 2014 Jul 30.

PMID:
24990399
9.

Pathogenetic mechanisms of amyloid A amyloidosis.

Simons JP, Al-Shawi R, Ellmerich S, Speck I, Aslam S, Hutchinson WL, Mangione PP, Disterer P, Gilbertson JA, Hunt T, Millar DJ, Minogue S, Bodin K, Pepys MB, Hawkins PN.

Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16115-20. doi: 10.1073/pnas.1306621110. Epub 2013 Aug 19.

10.

Mammalian phosphatidylinositol 4-kinases as modulators of membrane trafficking and lipid signaling networks.

Clayton EL, Minogue S, Waugh MG.

Prog Lipid Res. 2013 Jul;52(3):294-304. doi: 10.1016/j.plipres.2013.04.002. Epub 2013 Apr 19. Review.

11.

Phosphatidylinositol 4-kinases and PI4P metabolism in the nervous system: roles in psychiatric and neurological diseases.

Clayton EL, Minogue S, Waugh MG.

Mol Neurobiol. 2013 Feb;47(1):361-72. doi: 10.1007/s12035-012-8358-6. Epub 2012 Oct 10. Review.

PMID:
23054682
12.

Lipid rafts, microdomain heterogeneity and inter-organelle contacts: impacts on membrane preparation for proteomic studies.

Minogue S, Waugh MG.

Biol Cell. 2012 Oct;104(10):618-27. doi: 10.1111/boc.201200020. Epub 2012 Jul 24. Review.

PMID:
22694059
13.

The phosphatidylinositol 4-kinases: don't call it a comeback.

Minogue S, Waugh MG.

Subcell Biochem. 2012;58:1-24. doi: 10.1007/978-94-007-3012-0_1. Review.

PMID:
22403072
14.

CDP-diacylglycerol phospholipid synthesis in detergent-soluble, non-raft, membrane microdomains of the endoplasmic reticulum.

Waugh MG, Minogue S, Clayton EL, Hsuan JJ.

J Lipid Res. 2011 Dec;52(12):2148-58. doi: 10.1194/jlr.M017814. Epub 2011 Sep 21.

15.

Advanced glycation end products (AGEs) increase human mesangial foam cell formation by increasing Golgi SCAP glycosylation in vitro.

Yuan Y, Zhao L, Chen Y, Moorhead JF, Varghese Z, Powis SH, Minogue S, Sun Z, Ruan XZ.

Am J Physiol Renal Physiol. 2011 Jul;301(1):F236-43. doi: 10.1152/ajprenal.00646.2010. Epub 2011 Apr 20.

16.

Differential effects of the phosphatidylinositol 4-kinases, PI4KIIα and PI4KIIIβ, on Akt activation and apoptosis.

Chu KM, Minogue S, Hsuan JJ, Waugh MG.

Cell Death Dis. 2010;1:e106. doi: 10.1038/cddis.2010.84.

17.

Detergent-free isolation and characterization of cholesterol-rich membrane domains from trans-Golgi network vesicles.

Waugh MG, Chu KM, Clayton EL, Minogue S, Hsuan JJ.

J Lipid Res. 2011 Mar;52(3):582-9. doi: 10.1194/jlr.D012807. Epub 2010 Dec 29.

18.

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.

Bodin K, Ellmerich S, Kahan MC, Tennent GA, Loesch A, Gilbertson JA, Hutchinson WL, Mangione PP, Gallimore JR, Millar DJ, Minogue S, Dhillon AP, Taylor GW, Bradwell AR, Petrie A, Gillmore JD, Bellotti V, Botto M, Hawkins PN, Pepys MB.

Nature. 2010 Nov 4;468(7320):93-7. doi: 10.1038/nature09494. Epub 2010 Oct 20.

19.

Oxysterol binding protein-dependent activation of sphingomyelin synthesis in the golgi apparatus requires phosphatidylinositol 4-kinase IIα.

Banerji S, Ngo M, Lane CF, Robinson CA, Minogue S, Ridgway ND.

Mol Biol Cell. 2010 Dec;21(23):4141-50. doi: 10.1091/mbc.E10-05-0424. Epub 2010 Sep 29.

20.

Relationship between phosphatidylinositol 4-phosphate synthesis, membrane organization, and lateral diffusion of PI4KIIalpha at the trans-Golgi network.

Minogue S, Chu KM, Westover EJ, Covey DF, Hsuan JJ, Waugh MG.

J Lipid Res. 2010 Aug;51(8):2314-24. doi: 10.1194/jlr.M005751. Epub 2010 Apr 13.

21.

Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells.

Vigor KL, Kyrtatos PG, Minogue S, Al-Jamal KT, Kogelberg H, Tolner B, Kostarelos K, Begent RH, Pankhurst QA, Lythgoe MF, Chester KA.

Biomaterials. 2010 Feb;31(6):1307-15. doi: 10.1016/j.biomaterials.2009.10.036. Epub 2009 Nov 4.

PMID:
19889453
22.

Loss of phosphatidylinositol 4-kinase 2alpha activity causes late onset degeneration of spinal cord axons.

Simons JP, Al-Shawi R, Minogue S, Waugh MG, Wiedemann C, Evangelou S, Loesch A, Sihra TS, King R, Warner TT, Hsuan JJ.

Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11535-9. doi: 10.1073/pnas.0903011106. Epub 2009 Jul 6.

23.

Quantification of multiple phosphatidylinositol 4-kinase isozyme activities in cell extracts.

Waugh MG, Minogue S, Hsuan JJ.

Methods Mol Biol. 2009;462:279-89. doi: 10.1007/978-1-60327-115-8_19.

PMID:
19160677
24.

Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus.

Kogelberg H, Tolner B, Thomas GJ, Di Cara D, Minogue S, Ramesh B, Sodha S, Marsh D, Lowdell MW, Meyer T, Begent RH, Hart I, Marshall JF, Chester K.

J Mol Biol. 2008 Oct 3;382(2):385-401. doi: 10.1016/j.jmb.2008.07.013. Epub 2008 Jul 16.

25.

Daycase laparoscopic cholecystectomy: a prospective study of post-discharge pain, analgesic and antiemetic requirements.

Kavanagh T, Hu P, Minogue S.

Ir J Med Sci. 2008 Jun;177(2):111-5. doi: 10.1007/s11845-008-0131-5. Epub 2008 Feb 13.

PMID:
18270763
26.

Intravenous nalbuphine 50 microg x kg(-1) is ineffective for opioid-induced pruritus in pediatrics.

Nakatsuka N, Minogue SC, Lim J, Montgomery CJ, Court CA, Malherbe S, Csanyi-Fritz Y, Kearney RA, Phillips L, Reid K, Kingsley J, Ansermino JM.

Can J Anaesth. 2006 Nov;53(11):1103-10.

PMID:
17079637
27.

Intravenous nalbuphine 50 µg·kg(-1) is ineffective for opioid-induced pruritus in pediatrics.

Nakatsuka N, Minogue SC, Lim Masc J, Montgomery CJ, Court CA, Csanyi-Fritz Y, Ansermino JM, Malherbe S, Kearney RA, Phillips L, Reid K, Kingsley J.

Can J Anaesth. 2006 Nov;53(11):1103-10. doi: 10.1007/BF03022878.

PMID:
27518236
28.

Phosphatidylinositol 4-kinase is required for endosomal trafficking and degradation of the EGF receptor.

Minogue S, Waugh MG, De Matteis MA, Stephens DJ, Berditchevski F, Hsuan JJ.

J Cell Sci. 2006 Feb 1;119(Pt 3):571-81.

29.

Lipid and peptide control of phosphatidylinositol 4-kinase IIalpha activity on Golgi-endosomal Rafts.

Waugh MG, Minogue S, Chotai D, Berditchevski F, Hsuan JJ.

J Biol Chem. 2006 Feb 17;281(7):3757-63. Epub 2005 Oct 25.

30.

Bacteriostatic saline containing benzyl alcohol decreases the pain associated with the injection of propofol.

Minogue SC, Sun DA.

Anesth Analg. 2005 Mar;100(3):683-6, table of contents.

PMID:
15728052
31.

Laryngo-tracheo-bronchial stenosis in a patient with primary pulmonary amyloidosis: a case report and brief review.

Minogue SC, Morrisson M, Ansermino M.

Can J Anaesth. 2004 Oct;51(8):842-5.

PMID:
15470177
32.
33.
34.

Localization of a highly active pool of type II phosphatidylinositol 4-kinase in a p97/valosin-containing-protein-rich fraction of the endoplasmic reticulum.

Waugh MG, Minogue S, Anderson JS, Balinger A, Blumenkrantz D, Calnan DP, Cramer R, Hsuan JJ.

Biochem J. 2003 Jul 1;373(Pt 1):57-63.

35.

Signalling and non-caveolar rafts.

Waugh MG, Minogue S, Anderson JS, dos Santos M, Hsuan JJ.

Biochem Soc Trans. 2001 Aug;29(Pt 4):509-11. Review.

PMID:
11498019
36.

Cloning of a human type II phosphatidylinositol 4-kinase reveals a novel lipid kinase family.

Minogue S, Anderson JS, Waugh MG, dos Santos M, Corless S, Cramer R, Hsuan JJ.

J Biol Chem. 2001 May 18;276(20):16635-40. Epub 2001 Feb 13.

37.

Phosphoinositide 4- and 5-kinases and the cellular roles of phosphatidylinositol 4,5-bisphosphate.

Hsuan JJ, Minogue S, dos Santos M.

Adv Cancer Res. 1998;74:167-216. Review. No abstract available.

PMID:
9561269
38.

The Friedreich's ataxia gene encodes a novel phosphatidylinositol-4- phosphate 5-kinase.

Carvajal JJ, Pook MA, dos Santos M, Doudney K, Hillermann R, Minogue S, Williamson R, Hsuan JJ, Chamberlain S.

Nat Genet. 1996 Oct;14(2):157-62.

PMID:
8841185
39.

A contemporary approach to budget variance analysis: a pharmacy application.

Minogue S, Vogel DP.

Top Hosp Pharm Manage. 1989 Aug;9(2):1-10. No abstract available.

PMID:
10314354
40.

Alcohol and drugs.

Minogue SJ.

Med J Aust. 1973 Jul 7;2(1):50. No abstract available.

PMID:
4725476
41.

Hereditary mental defectives and their progeny.

Minogue SJ.

Med J Aust. 1969 Jun 28;1(26):1387. No abstract available.

PMID:
5797175
42.

Sex education in Australia.

Minogue SJ.

Med J Aust. 1968 Aug 17;2(7):337-8. No abstract available.

PMID:
5684798
43.

Korsakoff's disease due to lead and arsenic poisoning.

MINOGUE SJ.

Med J Aust. 1956 Jul 7;43(1):16-7. No abstract available.

PMID:
13347448
44.

Alcoholism.

MINOGUE SJ.

Med J Aust. 1954 Mar 6;41(1 10):358-9. No abstract available.

PMID:
13153564
45.

Delirium tremens.

MINOGUE SJ.

Med J Aust. 1952 Aug 16;2(7):254-5. No abstract available.

PMID:
12992160
46.

The over-emphasis on psychiatric symptoms.

MINOGUE SJ.

Med J Aust. 1949 Jan 29;1(5):130-3. No abstract available.

PMID:
18124659
47.

Alcoholics Anonymous.

MINOGUE SJ.

Med J Aust. 1948 May 8;1(19):586. No abstract available.

PMID:
18868217
48.

Alcoholism.

MINOGUE SJ.

Med J Aust. 1946 Aug 24;2:271-3. No abstract available.

PMID:
20996244

Supplemental Content

Loading ...
Support Center